Evidence map›Paper›PMID 41085485›Full record

ArticleJournal of the International AIDS Society2025

Retention in a low-resource, high-burden South African cohort on antiretroviral therapy: Retrospective, longitudinal analysis comparing six measures of retention.

Claire M Keene, Jonathan Euvrard, Tamsin K Phillips, Mike English, Jacob McKnight, Catherine Orrell

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Claire M KeeneCentre for Global Health Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Jonathan EuvrardCentre for Integrated Data and Epidemiological Research, School of Public Health, University of Cape Town, Cape Town, South Africa.ORCID https://orcid.org/0000-0002-3937-7855
Tamsin K PhillipsDivision of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.ORCID https://orcid.org/0000-0003-4554-2922
Mike EnglishCentre for Global Health Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Jacob McKnightCentre for Global Health Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Catherine OrrellDepartment of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Funding

University of Oxford
6 · The paper itself

Abstract

introductionRetention on antiretroviral therapy (ART) is a prerequisite for adherence and subsequent treatment success. Measuring retention is also easily implementable at facility and population levels, making it pragmatic to monitor ART programme success. However, despite its ubiquitous global use, there is little consistency in the measurement of retention.

methodsThis study retrospectively applied six measures of retention to one cohort of adults (initiating ART after 01-09-2016, with ≥1 year of observation time to database closure on 30-09-2022), in a low-resource, high HIV-burden setting in South Africa. Using routine healthcare data from the Western Cape's Provincial Health Data Centre, loss to follow-up (LTFU), fixed-point retention, visit constancy, visit gaps, treatment interruptions and medication possession ratio (MPR) were described over 5 years from initiation. Individuals were considered "continuously retained" if they did not experience attrition throughout their observed follow-up. Measures were compared using the proportion misassigned and Cohen's Kappa statistic.

resultsThe median age of the cohort (n = 68,888) was 31 years (interquartile range [IQR] 26-38) at initiation, with 69% (47,631/68,888) female, and a median observed follow-up of 4 years (IQR 3-5). Across different measures, retention was low, and declined over time. There was variable overlap; the proportion continuously retained throughout their observed follow-up ranged from 60% (41,268/68,888 not LTFU) to 32% (22,381/68,888 MPR ≥80%). Retention by all measures was strongly associated with viral suppression.

conclusionsBy all measures, large proportions of people in this setting were considered out of ART care during 5 years of observed follow-up time from initiation. This makes retention a critical target for intervention to improve population-level viral suppression and achieve epidemic control. Measuring longitudinal retention revealed that most people disengaged from ART care at some point after initiation. Certain measures of retention (e.g. treatment interruptions) identified people in and out of care with more granularity, whereas blunter measures (e.g. LTFU) misassigned individuals' retention status and missed patterns of retention over time as people cycled in and out of care between points of measurement. Ultimately, the choice of measure depends on the purpose of the evaluation and on the data available, but, where possible, more granular measures are recommended.

Indexed as

Anti-HIV AgentsAnti-Retroviral AgentsHIV InfectionsMedication AdherenceRetention in CareAdultFemaleHumansLongitudinal StudiesLost to Follow-UpMaleMiddle AgedRetrospective StudiesSouth AfricaYoung AdultAnti-HIV AgentsAnti-Retroviral Agentsantiretroviral therapyengagementlongitudinalmeasurementretention

Identifiers

PMID41085485
PMCPMC12519882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.